Product Description

Product Summary

Wellbutrin XL is a prescription antidepressant classified as a norepinephrine-dopamine reuptake inhibitor (NDRI). Each extended-release tablet delivers 24-hour coverage for major depressive disorder (MDD), seasonal affective disorder (SAD), and smoking cessation. Available in Kenyan pharmacies only with a psychiatrist’s prescription due to controlled substance regulations.

Key Benefits

• Unique Mechanism: Increases dopamine/norepinephrine (unlike SSRIs), improving motivation, focus, and energy.
• Minimal Sexual Side Effects: Unlike SSRIs, rarely causes libido loss or erectile dysfunction.
• Weight-Neutral: Does not typically cause weight gain (may aid weight loss in some patients).
• Smoking Cessation: Reduces nicotine cravings (used as Zyban in cessation programs).
• Once-Daily Dosing: XL formulation provides steady 24-hour symptom control.

Composition

Active Ingredient per Tablet:

• Bupropion Hydrochloride:
  • 150mg (white tablet)
  • 300mg (purple tablet)

Other Ingredients:
Hypromellose, microcrystalline cellulose, polyethylene glycol, titanium dioxide, iron oxide red (300mg only).

Free From:
Lactose, gluten.

Bioavailability:
Extended-release coating ensures gradual absorption; peak plasma levels in 5 hours. Avoid crushing/chewing.

How to Use

Dosage:

• MDD/SAD: Start 150mg once daily for 3 days, then increase to 300mg once daily.
• Smoking Cessation: 150mg once daily for 3 days, then 300mg once daily for 7–12 weeks.
• Max Dose: 300mg/day (higher seizure risk).

Timing:

• Take in the morning to avoid insomnia.
• Swallow whole; do not crush/chew (alters release).

Duration:

• Depression: 6+ months; taper slowly to avoid discontinuation syndrome.
• Smoking Cessation: Short-term (12 weeks max).

Potential Side Effects

Common Reactions:

• Insomnia, dry mouth, headache, nausea.
• Anxiety, tremor, sweating.
• Appetite suppression/weight loss.

Serious Risks (Rare):

• Seizures: Risk increases at >300mg/day, history of seizures, or eating disorders.
• Hypertension: Monitor blood pressure (dose-dependent).
• Mania: May trigger bipolar episodes (screen for bipolar disorder first).
• Suicidal Ideation: Risk in young adults (<25 yrs) during initial treatment.
• Liver Toxicity: Rare (monitor for jaundice, dark urine).

Precautions:

• Avoid if:
  • Seizure disorder, brain tumor, or abrupt alcohol/benzodiazepine withdrawal.
  • Eating disorders (anorexia/bulimia).
  • MAOI use within 14 days.
• Medical History:
  • Bipolar disorder, hypertension, liver/kidney disease.
  • Head trauma, diabetes, or substance use disorder.
• Drug Interactions:
  • MAOIs (e.g., phenelzine): Fatal interaction (wait 14 days between doses).
  • Antipsychotics (e.g., risperidone): Lower seizure threshold.
  • Theophylline/Systemic Steroids: Increase seizure risk.
  • Tamoxifen: Reduces efficacy (bupropion induces CYP2D6).
• Pregnancy/Breastfeeding: Use only if benefits outweigh risks (neonatal withdrawal possible).

Frequently Asked Questions (FAQs)

1. Is Wellbutrin XL available over-the-counter in Kenya?
   No – prescription-only. Available as Bupron XL or Zyban (for smoking cessation) in major hospitals/pharmacies (e.g., Nairobi Hospital, Aga Khan).

2. How much does it cost?
   ~KES 8,000–15,000/month (150mg/300mg); rarely covered by NHIF.

3. Why choose Wellbutrin over SSRIs?
   Ideal for depression with fatigue, apathy, or sexual dysfunction from SSRIs. Avoids weight gain.

4. Can it be used for ADHD?
   Off-label for ADHD (improves focus), but not first-line in Kenya (methylphenidate preferred).

5. How does it benefit users in Kenya?

   • Stigma Reduction: Minimal sexual side effects encourage adherence.
   • Smoking Cessation: Supports Kenya’s tobacco control efforts.
   • Energy Restoration: Counters depression-related fatigue in high-stress urban settings.

6. What if I miss a dose?
   Skip if near next dose. Never double-dose. Resume next morning.

7. Can I drink alcohol?
   Avoid – increases seizure risk and worsens depression.

8. Are there Kenyan alternatives?
   SSRIs (e.g., fluoxetine, sertraline) or SNRIs (e.g., venlafaxine). For smoking cessation: nicotine gum/patches.

Who Can Benefit

• Adults with treatment-resistant depression (SSRI non-responders).
• Patients with depression + fatigue/low motivation.
• Those experiencing sexual side effects from SSRIs.
• Smokers motivated to quit (with behavioral support).
• Adults with seasonal affective disorder (SAD).